Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cellular and Molecular Life Sciences : CMLS|January 18, 2003
Mitochondrial biogenesis in brown adipose tissue is associated with differential expression of transcription regulatory factorsJ A Villena, M C Carmona, M Rodriguez de la Concepción, et al.
Clinical Rheumatology|November 17, 2006
Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoidsR Sanmartí, A Gómez-Centeno, G Ercilla, et al.
Annals of the Rheumatic Diseases|April 16, 2003
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathyR Cervera, O Viñas, M Ramos-Casals, et al.
European Journal of Immunology|April 1, 1991
Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibodyM Plana, O Viñas, O De la Calle-Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1995
Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patientsM R Pino-Otín, O Viñas, M A de la Fuente, et al.
The Journal of Experimental Medicine|June 1, 1994
CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell lineM Juan, O Viñas, M R Pino-Otín, et al.
Tissue Antigens|July 1, 1995
CD50 (intercellular adhesion molecule-3) is expressed at higher levels on memory than on naive human T cells but induces a similar calcium mobilization on both subsetsM R Pino-Otín, M Juan, M A de la Fuente, et al.
Clinical and Experimental Rheumatology|June 5, 2007
Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical settingI Vázquez, E Graell, J Gratacós, et al.
Lupus|June 3, 2016
International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodiesC Bentow, G Lakos, P Martis, et al.
Pageof 6